These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 9042310

  • 1. Tiazofurin effects on IMP-dehydrogenase activity and expression in the leukemia cells of patients with CML blast crisis.
    Wright DG, Boosalis MS, Waraska K, Oshry LJ, Weintraub LR, Vosburgh E.
    Anticancer Res; 1996; 16(6A):3349-51. PubMed ID: 9042310
    [Abstract] [Full Text] [Related]

  • 2. Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
    Tricot G, Weber G.
    Anticancer Res; 1996; 16(6A):3341-7. PubMed ID: 9042309
    [Abstract] [Full Text] [Related]

  • 3. Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part I. In vivo studies.
    Malek K, Boosalis MS, Waraska K, Mitchell BS, Wright DG.
    Leuk Res; 2004 Nov; 28(11):1125-36. PubMed ID: 15380335
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tiazofurin: biological effects and clinical uses.
    Tricot G, Jayaram HN, Weber G, Hoffman R.
    Int J Cell Cloning; 1990 May; 8(3):161-70. PubMed ID: 2189014
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Efficacy of imatinib mesylate, a specific inhibitor of BCR/ABL tyrosine kinase, on chronic myeloid leukemia in blast phase].
    Zhang GC, Zheng D, Li QH, Li XH, Cai CC, Luo SK, Li J, Peng AH, Tong XZ, Tan EX, Hong WD.
    Ai Zheng; 2004 Dec; 23(12):1696-9. PubMed ID: 15601563
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chronic myeloid leukemia blast crisis arises from progenitors.
    Michor F.
    Stem Cells; 2007 May; 25(5):1114-8. PubMed ID: 17218393
    [Abstract] [Full Text] [Related]

  • 16. Selective up-regulation of type II inosine 5'-monophosphate dehydrogenase messenger RNA expression in human leukemias.
    Nagai M, Natsumeda Y, Konno Y, Hoffman R, Irino S, Weber G.
    Cancer Res; 1991 Aug 01; 51(15):3886-90. PubMed ID: 1677309
    [Abstract] [Full Text] [Related]

  • 17. Biochemical consequences of resistance to a recently discovered IMP dehydrogenase inhibitor, benzamide riboside, in human myelogenous leukemia K562 cells.
    Jayaram HN, O'Connor A, Grant MR, Yang H, Grieco PA, Cooney DA.
    J Exp Ther Oncol; 1996 Sep 01; 1(5):278-85. PubMed ID: 9414415
    [Abstract] [Full Text] [Related]

  • 18. Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up.
    Palandri F, Castagnetti F, Testoni N, Luatti S, Marzocchi G, Bassi S, Breccia M, Alimena G, Pungolino E, Rege-Cambrin G, Varaldo R, Miglino M, Specchia G, Zuffa E, Ferrara F, Bocchia M, Saglio G, Pane F, Alberti D, Martinelli G, Baccarani M, Rosti G, GIMEMA Working Party on Chronic Myeloid Leukemia.
    Haematologica; 2008 Dec 01; 93(12):1792-6. PubMed ID: 18838477
    [Abstract] [Full Text] [Related]

  • 19. Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells.
    Nimmanapalli R, Fuino L, Bali P, Gasparetto M, Glozak M, Tao J, Moscinski L, Smith C, Wu J, Jove R, Atadja P, Bhalla K.
    Cancer Res; 2003 Aug 15; 63(16):5126-35. PubMed ID: 12941844
    [Abstract] [Full Text] [Related]

  • 20. Imatinib mesylate as treatment for blastic transformation of Philadelphia chromosome positive chronic myelogenous leukemia.
    Sureda A, Carrasco M, de Miguel M, Martínez JA, Conde E, Sanz MA, Díaz-Mediavilla J, Sierra J.
    Haematologica; 2003 Nov 15; 88(11):1213-20. PubMed ID: 14607749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.